When to Start Prednisolone in ITP
Prednisolone should be initiated in adults with newly diagnosed ITP when the platelet count is ≤30 × 10⁹/L, and in children only when there is more than mild bleeding (beyond skin manifestations alone), regardless of platelet count. 1
Adults with Newly Diagnosed ITP
For adults, the threshold is clear and platelet count-driven:
- Start treatment when platelets ≤30 × 10⁹/L 1
- Longer courses of corticosteroids are preferred over shorter courses as first-line treatment 1
- The typical dosing ranges from 1 mg/kg/day (standard prednisone) to higher doses depending on severity 2
Key consideration: This recommendation is grade 2C, meaning it's based on moderate-quality evidence. The decision balances bleeding risk against corticosteroid side effects. Asymptomatic patients with platelets >30 × 10⁹/L can often be observed without immediate treatment.
Children with Newly Diagnosed ITP
The pediatric approach is fundamentally different and bleeding-based rather than platelet count-based:
- Children with no bleeding or mild bleeding (skin manifestations only—bruising and petechiae) should be managed with observation alone, regardless of platelet count 1
- Treatment is indicated when bleeding extends beyond skin (e.g., epistaxis lasting >15 minutes, mucosal bleeding, or other significant hemorrhage) 1
When treatment is needed in children:
- Either a short course of corticosteroids OR a single dose of IVIg (0.8-1 g/kg) are first-line options 1
- If using prednisolone: 4 mg/kg/day for 4-7 days is effective 3, 4
- IVIg produces faster platelet recovery (median 2 days vs 4 days with prednisone) but both are acceptable 5
Critical pitfall: The 2019 guidelines emphasize that 75-80% of children enter remission by 6 months regardless of treatment 1. Overtreatment with corticosteroids exposes children to unnecessary side effects without changing long-term outcomes. The goal is hemorrhage prevention, not platelet normalization.
Special Circumstances Requiring More Rapid Treatment
Use IVIg with corticosteroids when faster platelet increase is required 1:
- Active significant bleeding
- Need for urgent procedures
- Very low platelets (<10 × 10⁹/L) with high-risk features
Adolescents (Age 10+ years)
Adolescents have higher rates of chronic ITP (47.3% vs 23.1% in younger children) 1, but should still be managed using pediatric bleeding-based criteria rather than adult platelet count-based thresholds. There is no evidence supporting different treatment approaches for this age group 1.
What NOT to Do
- Do not treat children with isolated thrombocytopenia and only skin findings, even if platelets are <10 × 10⁹/L 1
- Do not use long-term corticosteroids in children with acute ITP due to side effects 1
- Do not delay treatment in adults with platelets ≤20 × 10⁹/L and significant bleeding risk 5
The evidence consistently shows that in children, observation is safe for those without significant bleeding, while adults benefit from a platelet count threshold approach to prevent hemorrhagic complications.